Hemolytic uremic syndrome: an unusual complication of interferon-β treatment in a MS patient

J Neurol. 2013 Jul;260(7):1915-6. doi: 10.1007/s00415-013-6961-8. Epub 2013 May 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adjuvants, Immunologic / adverse effects*
  • Adjuvants, Immunologic / therapeutic use
  • Adult
  • Female
  • Hemolytic-Uremic Syndrome / chemically induced*
  • Humans
  • Interferon-beta / adverse effects*
  • Interferon-beta / therapeutic use
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Adjuvants, Immunologic
  • Interferon-beta